Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 770

 

Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 
     
ORIGINAL ARTICLE
Year : 2019  |  Volume : 9  |  Issue : 3  |  Page : 127-131

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type iii open orthopedic fractures


1 Department of Pharmacy, St. Luke's University Health Network, PA, USA
2 Department of Pharmacy, Good Samaritan Hospital, San Jose, CA, USA
3 Department of Medicine, Section of Infectious Diseases, St. Luke's University Health Network, Bethlehem, PA, USA

Correspondence Address:
Dr. Shawn C Depcinski
St. Luke's University Health Network, 801 Ostrum Street, Bethlehem, PA 18015
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJCIIS.IJCIIS_7_19

Rights and Permissions

Context: Uncertainty of antibiotic prophylaxis of type III open orthopedic fractures still exists. Controversy remains as using cefazolin as a single agent or the addition of an aminoglycoside for broader coverage to prevent infection. Aims: The aim of the study was to determine if the combination of cefazolin and an aminoglycoside reduced infections compared with cefazolin alone. Subjects and Methods: This was a retrospective study inclusive of patients with type III open fracture admitted between January 1, 2010, and August 31, 2014 at a level 1 trauma center, who were prophylactically treated with cefazolin alone or cefazolin and an aminoglycoside. Statistical Analysis Used: All analyses were performed using Microsoft Excel 2010. Chi-square or Fisher's exact tests were used for categorical data and Wilcoxon rank-sum test for skewed continuous data. Logistic regression analysis was performed on all confounding variables with P < 0.1. Results: A significantly higher percentage in the combination group developed infection (6/15 [40%] vs. 8/53 [15.1%], P= 0.035). There was a trend toward a higher odds of infection in the combination group (odds ratio: 2.99, 95% confidence interval: 0.79–11.33, P= 0.107). Infection rates due to multidrug-resistant bacteria were statistically higher with the combination group (3/15 [20%] vs. 1/53 [1.9%], P= 0.046). There were no statistically significant differences in 30-day mortality, 1-year readmission rates due to fracture complication, or length of hospital stay. Conclusions: The results suggest that the addition of an aminoglycoside to cefazolin may not be necessary to prevent infection.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed332    
    Printed19    
    Emailed0    
    PDF Downloaded22    
    Comments [Add]    

Recommend this journal